| scholarly article | Q13442814 |
| P2093 | author name string | N G Ahn | |
| S C Chow | |||
| J E Eriksson | |||
| S E Tran | |||
| T H Holmström | |||
| V L Johnson | |||
| P2860 | cites work | FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis | Q24307362 |
| Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis | Q24307757 | ||
| MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase | Q24315104 | ||
| Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes | Q24315805 | ||
| Daxx, a Novel Fas-Binding Protein That Activates JNK and Apoptosis | Q24316216 | ||
| Inhibition of death receptor signals by cellular FLIP | Q24316446 | ||
| Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death | Q24336389 | ||
| Tight control of gene expression in mammalian cells by tetracycline-responsive promoters | Q24564850 | ||
| Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor | Q24597543 | ||
| The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins | Q28117866 | ||
| FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). | Q28240752 | ||
| Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation | Q28263551 | ||
| FAP-1: a protein tyrosine phosphatase that associates with Fas | Q28287693 | ||
| MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1 | Q28302936 | ||
| PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo | Q28609356 | ||
| Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product | Q28639862 | ||
| CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis | Q70915079 | ||
| Apoptosis and the cell cycle | Q71017073 | ||
| Fas-induced apoptosis is mediated by activation of a Ras and Rac protein-regulated signaling pathway | Q71574095 | ||
| Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor | Q71693197 | ||
| Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape | Q71762882 | ||
| Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? | Q71840957 | ||
| Antitumor effect of locally produced CD95 ligand | Q73034275 | ||
| Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma | Q73939838 | ||
| Anti-Fas induces apoptosis and proliferation in human dermal fibroblasts: differences between foreskin and adult fibroblasts | Q74276848 | ||
| Suppression of Fas/APO-1-mediated apoptosis by mitogen-activated kinase signaling | Q74336476 | ||
| Phosphorylation of FADD/MORT1 and Fas by kinases that associate with the membrane-proximal cytoplasmic domain of Fas | Q74557558 | ||
| Apoptosis: alive and kicking in 1997 | Q80818125 | ||
| Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis | Q29547567 | ||
| Regulation of neuronal survival by the serine-threonine protein kinase Akt | Q29614185 | ||
| TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB | Q29614706 | ||
| An essential role for NF-kappaB in preventing TNF-alpha-induced cell death | Q29614707 | ||
| A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry | Q29617253 | ||
| The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis | Q29618601 | ||
| Transformation of mammalian cells by constitutively active MAP kinase kinase | Q29618686 | ||
| Suppression of TNF-alpha-induced apoptosis by NF-kappaB | Q29618717 | ||
| Two CD95 (APO-1/Fas) signaling pathways | Q29619631 | ||
| The Fas death factor | Q29620461 | ||
| The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death | Q29620519 | ||
| Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. | Q30452681 | ||
| A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor | Q34661010 | ||
| Cell death by apoptosis and its protective role against disease | Q36327633 | ||
| The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand | Q36367323 | ||
| Programmed cell death: apoptosis and oncogenesis. | Q36399233 | ||
| Insulin stimulation of a MEK-dependent but ERK-independent SOS protein kinase | Q36557097 | ||
| CD95 (APO-1/Fas)-associating signalling proteins | Q36688414 | ||
| Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures. Some pitfalls in staining and data analysis | Q36757507 | ||
| Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors | Q36852093 | ||
| A mouse Fas-associated protein with homology to the human Mort1/FADD protein is essential for Fas-induced apoptosis | Q38357354 | ||
| Co-regulation of two gene activities by tetracycline via a bidirectional promoter. | Q40395769 | ||
| Apoptosis in cancer therapy: crossing the threshold | Q40694262 | ||
| Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast | Q40974442 | ||
| Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis | Q41048010 | ||
| Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases. | Q41075660 | ||
| Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade | Q41109047 | ||
| Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. | Q41128352 | ||
| Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase | Q41191845 | ||
| Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis. | Q41205660 | ||
| PI3K: downstream AKTion blocks apoptosis | Q41351876 | ||
| Cell death induction by TNF: a matter of self control | Q41468884 | ||
| Effect of bcl-2 on Fas antigen-mediated cell death | Q41542115 | ||
| A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen | Q41553101 | ||
| PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond | Q41596068 | ||
| Signal transduction through MAP kinase cascades | Q41750250 | ||
| Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts | Q42528899 | ||
| Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate | Q42556020 | ||
| Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway | Q42618265 | ||
| Role of mitogen-activated protein kinase kinase in regulation of the epidermal growth factor receptor by protein kinase C. | Q42812845 | ||
| Identification of a human epidermal growth factor receptor-associated protein kinase as a new member of the mitogen-activated protein kinase/extracellular signal-regulated protein kinase family | Q44435083 | ||
| Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins | Q46354498 | ||
| Inhibition of apoptosis as a mechanism of tumor promotion | Q46817828 | ||
| FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway | Q46885906 | ||
| Interdependent domains controlling the enzymatic activity of mitogen-activated protein kinase kinase 1. | Q52198227 | ||
| The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis. | Q52207161 | ||
| Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. | Q54136924 | ||
| Dominance of resistance to the cytocidal effect of tumor necrosis factor in heterokaryons formed by fusion of resistant and sensitive cells. | Q54383548 | ||
| Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin | Q64390050 | ||
| Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669 | Q68248821 | ||
| Mitogen-activated protein kinase regulates the epidermal growth factor receptor through activation of a tyrosine phosphatase | Q70460804 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 5991-6002 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis | |
| P478 | volume | 19 |
| Q34661998 | 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades |
| Q34868977 | A characterization of four B16 murine melanoma cell sublines molecular fingerprint and proliferation behavior |
| Q40164019 | A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells |
| Q40644298 | Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria |
| Q35221788 | Activation of mitogen-activated protein kinase is required for migration and invasion of placental site trophoblastic tumor |
| Q40811155 | Activation of protein kinase C inhibits TRAIL-induced caspases activation, mitochondrial events and apoptosis in a human leukemic T cell line |
| Q30428706 | Application of insulin-like growth factor-1 in the treatment of inner ear disorders |
| Q38343112 | Bax is upregulated by p53 signal pathway in the SPE B-induced apoptosis |
| Q44040283 | Blocking NF-kappaB activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effector. |
| Q38289911 | CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis |
| Q40568789 | Caspase-1 mediates Fas-induced apoptosis and is up-regulated by interferon-gamma in human astrocytoma cells |
| Q40619032 | Characterization of p21Ras‐mediated apoptosis induced by protein kinase C inhibition and application to human tumor cell lines |
| Q44523404 | Chelerythrin activates caspase-8, downregulates FLIP long and short, and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cells |
| Q44491847 | Chronic regulation of the expression of the gap junction protein connexin 43 in transfected HeLa cells |
| Q30506115 | Clustering induces a lateral redistribution of alpha 2 beta 1 integrin from membrane rafts to caveolae and subsequent protein kinase C-dependent internalization. |
| Q36087586 | Control of Mitochondrial Dynamics by Fas-induced Caspase-8 Activation in Hippocampal Neurons |
| Q34675896 | Cross signaling, cell specificity, and physiology |
| Q34293560 | Development of anticancer drugs targeting the MAP kinase pathway |
| Q40555313 | Differential regulation of the mitochondrial and death receptor pathways in neural stem cells |
| Q39745271 | Effect of ERK inhibitor on pulmonary metastasis of inoculated human adenoid cystic carcinoma cells in nude mice |
| Q28574580 | Effect of cocaine on Fas-associated protein with death domain in the rat brain: individual differences in a model of differential vulnerability to drug abuse |
| Q46947457 | Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1/2 MAP kinase pathway. |
| Q40618698 | Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector |
| Q39700468 | Erythroid differentiation sensitizes K562 leukemia cells to TRAIL-induced apoptosis by downregulation of c-FLIP. |
| Q33837045 | FLIP protects against hypoxia/reoxygenation-induced endothelial cell apoptosis by inhibiting Bax activation |
| Q28138764 | Glutamine-dependent antiapoptotic interaction of human glutaminyl-tRNA synthetase with apoptosis signal-regulating kinase 1 |
| Q40549981 | Heat stress downregulates FLIP and sensitizes cells to Fas receptor-mediated apoptosis. |
| Q24673364 | Inactivation of Dual-Specificity Phosphatases Is Involved in the Regulation of Extracellular Signal-Regulated Kinases by Heat Shock and Hsp72 |
| Q36244342 | Increased expression but not sensitivity to Fas/CD95 in glioblastoma cells depleted of mitochondrial DNA. |
| Q78758328 | Integrin alpha2beta1 inhibits Fas-mediated apoptosis in T lymphocytes by protein phosphatase 2A-dependent activation of the MAPK/ERK pathway |
| Q53624724 | Involvement of protein kinase B and mitogen-activated protein kinases in experimental normothermic liver ischaemia-reperfusion injury. |
| Q40844684 | Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase |
| Q40430386 | MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly |
| Q36244064 | MEK inhibition suppresses cell invasion and migration in ovarian cancers with activation of ERK1/2. |
| Q36285442 | Matrix-independent survival of human keratinocytes through an EGF receptor/MAPK-kinase-dependent pathway |
| Q36728699 | Molecular mechanisms contributing to glutamine-mediated intestinal cell survival |
| Q36660550 | NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype |
| Q35027076 | Nitrosylation: the next phosphorylation? |
| Q30886621 | Nrf2 is an inhibitor of the Fas pathway as identified by Achilles' Heel Method, a new function-based approach to gene identification in human cells |
| Q44788463 | NuMA and nuclear lamins are cleaved during viral infection--inhibition of caspase activity prevents cleavage and rescues HeLa cells from measles virus-induced but not from rhinovirus 1B-induced cell death |
| Q35747267 | Oral graft-versus-host disease and programmed cell death: pathogenetic and clinical correlates |
| Q40748097 | Overexpression of the mouse Fas gene in human Hep3B hepatoma cells overcomes their resistance to Fas-mediated apoptosis |
| Q40765687 | Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated polypeptide with death domain |
| Q40625444 | Prevention of TNF-α-induced apoptosis in polyamine-depleted IEC-6 cells is mediated through the activation of ERK1/2 |
| Q37446086 | Procaspase 8 and Bax are up-regulated by distinct pathways in Streptococcal pyrogenic exotoxin B-induced apoptosis |
| Q44550507 | Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling |
| Q40424237 | Rapid turnover of c-FLIPshort is determined by its unique C-terminal tail |
| Q34117899 | Regulation of death receptor-mediated apoptosis pathways |
| Q33922202 | Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells |
| Q42182238 | Reversing multidrug resistance in hepatocellular carcinoma cells by inhibiting extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activity |
| Q42846305 | SBDS-deficiency results in deregulation of reactive oxygen species leading to increased cell death and decreased cell growth |
| Q39704059 | Silencing of Nuclear Mitotic Apparatus protein (NuMA) accelerates the apoptotic disintegration of the nucleus |
| Q35183209 | Survival signals in leukemic large granular lymphocytes |
| Q34605237 | The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia |
| Q40758343 | The intermediate filament protein keratin 8 is a novel cytoplasmic substrate for c-Jun N-terminal kinase. |
| Q64097858 | Transcriptomics Analysis of Circular RNAs Differentially Expressed in Apoptotic HeLa Cells |
| Q33964325 | Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells |
| Q40623315 | Type-2A protein phosphatase activity is required to maintain death receptor responsiveness. |
| Q98386303 | hsa-microRNA-411-5p regulates proliferation, migration and invasion by targeting the hyaluronan mediated motility receptor in ovarian cancer |
| Q40533259 | p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L). |
Search more.